Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes

doi:10.1084/jem.175.5.1195

This Article

	Full Text (PDF, 993K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Franco, A.
	Articles by Barnaba, V.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Franco, A.
	Articles by Barnaba, V.


Social Bookmarking

	What's this?

ARTICLES

Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes

A Franco, M Paroli, U Testa, R Benvenuto, C Peschle, F Balsano and V Barnaba
Immunology Unit, Universita La Sapienza, Rome, Italy.

Human activated T lymphocytes expressing class II molecules are able to present only complex antigens that bind to their own surface receptors, and thus can be captured, internalized, and processed through the class II major histocompatibility complex processing pathway. We have used the antigen-presenting T cell system to identify the viral receptor used by hepatitis B virus (HBV) to enter cells, as well as the sequence of HB envelope antigen (HBenvAg) involved in this interaction. Results show that both CD4+ and CD8+ T clones can process and present HBenvAg to class II-restricted cytotoxic T lymphocytes and that the CD71 transferrin receptor (TfR) is involved in efficient HBenvAg uptake by T cells. Moreover, we provide evidence that the HBenvAg sequence interacting with the T cell surface is contained within the pre-S2 region. Since TfR is also expressed on hepatocytes, it might represent a portal of cellular entry for HBV infection. This system of antigen presentation by T cells may serve as a model to study both lymphocyte receptors used by lymphocytotropic viruses and viral proteins critical to bind them.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Schafer, R., Kehlbach, R., Wiskirchen, J., Bantleon, R., Pintaske, J., Brehm, B. R., Gerber, A., Wolburg, H., Claussen, C. D., Northoff, H. (2007). Transferrin Receptor Upregulation: In Vitro Labeling of Rat Mesenchymal Stem Cells with Superparamagnetic Iron Oxide. Radiology 244: 514-523 [Abstract] [Full Text]
Deng, Q., Zhai, J.-w., Michel, M.-L., Zhang, J., Qin, J., Kong, Y.-y., Zhang, X.-x., Budkowska, A., Tiollais, P., Wang, Y., Xie, Y.-h. (2007). Identification and Characterization of Peptides That Interact with Hepatitis B Virus via the Putative Receptor Binding Site. J. Virol. 81: 4244-4254 [Abstract] [Full Text]
Wong, A. W., Ghosh, N., McKinnon, K. P., Reed, W., Piskurich, J. F., Wright, K. L., Ting, J. P.-Y. (2002). Regulation and Specificity of MHC2TA Promoter Usage in Human Primary T Lymphocytes and Cell Line. J. Immunol. 169: 3112-3119 [Abstract] [Full Text]
Chisari, F. V. (2000). Viruses, Immunity, and Cancer: Lessons from Hepatitis B. Am. J. Pathol. 156: 1117-1132 [Full Text]
Harvey, T., Macnaughton, T., Park, D., Gowans, E. (1999). A cellular protein which binds hepatitis B virus but not hepatitis B surface antigen. J. Gen. Virol. 80: 607-615 [Abstract]
Lanzavecchia, A (1993). Identifying strategies for immune intervention. Science 260: 937-944 [Abstract]
De Falco, S., Ruvoletto, M. G., Verdoliva, A., Ruvo, M., Raucci, A., Marino, M., Senatore, S., Cassani, G., Alberti, A., Pontisso, P., Fassina, G. (2001). Cloning and Expression of a Novel Hepatitis B Virus-binding Protein from HepG2 Cells. J. Biol. Chem. 276: 36613-36623 [Abstract] [Full Text]